Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer.

Medicine (Baltimore)

From the Department of Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun (SYL); Department of Surgery, Seoul National University Bundang Hospital, Seongnam (D-WK, MHI, H-KO, S-BK); Korean Hereditary Tumor Registry, Seoul National University College of Medicine, Seoul (D-WK); Department of Pathology, Seoul National University Bundang Hospital, Seongnam (HSL); Department of Surgery, Severance Hospital, Yonsei University College of Medicine (BSM, WRK, KYL, NKK); and Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (JWH, J-AY, WYL, HCK).

Published: December 2015

AI Article Synopsis

  • This study focuses on the clinicopathologic characteristics and survival outcomes of microsatellite instability-low (MSI-L) colorectal cancers (CRCs) compared to microsatellite stable (MSS) CRCs.
  • Out of 3019 patients reviewed, MSI-L accounted for 6.6% of the cases, with some differences noted in tumor location and size, but no significant differences in survival rates.
  • Importantly, MSI-L was found to be an independent prognostic factor for poorer overall survival, suggesting that it may hold clinical significance despite similarities to MSS CRCs.

Article Abstract

Although microsatellite instability-high (MSI-H) colorectal cancers (CRCs) have been shown to exhibit a distinct phenotype, the clinical value of MSI-low (MSI-L) in CRC remains unclear. We designed this study to examine the clinicopathologic characteristics and oncologic implications associated with MSI-L CRCs. We retrospectively reviewed data of CRC patients from 3 tertiary referral hospitals in Korea, who underwent surgical resection between January 2003 and December 2009 and had available MSI testing results. MSI testing was performed using the pentaplex Bethesda panel. Clinicopathologic features and oncologic outcomes were compared between MSI-L and microsatellite stable (MSS) CRCs; prognostic factors for survival were also examined. Of the 3019 patients reviewed, 2621 (86.8%) were MSS, and 200 (6.6%) were MSI-L; the remaining 198 (6.6%) were MSI-H. MSI-L and MSS CRCs were comparable in terms of their clinicopathologic features, with the exception of proximal tumor location (MSI-L 30.0% vs MSS 22.1%, P = 0.024) and tumor size (MSI-L 5.2 ± 2.6  cm vs MSS 4.6 ± 2.1  cm, P = 0.001). No differences were detected in either 3-year disease-free survival (MSI-L 87.2% vs MSS 82.6%, P = 0.121) or 5-year overall survival (OS) (MSI-L 74.2% vs MSS 78.3%, P = 0.131) by univariable analysis. However, MSI-L was an independent prognostic factor for poor OS by Cox regression analysis (hazard ratio 1.358, 95% confidence interval 1.014-1.819, P = 0.040). MSI-L may be an independent prognostic factor for OS in sporadic CRCs despite their clinicopathologic similarity to MSS. Further studies investigating the significance of MSI-L in the genesis and prognosis of CRCs are needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058919PMC
http://dx.doi.org/10.1097/MD.0000000000002260DOI Listing

Publication Analysis

Top Keywords

prognostic factor
12
msi-l
12
factor sporadic
8
msi testing
8
clinicopathologic features
8
mss
8
mss crcs
8
survival msi-l
8
msi-l independent
8
independent prognostic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!